ASRS V1.1 Screener ADHD

Features Assessments Pricing Practitioner sign in Create account

Conduct psychological assessments remotely, get scores automatically, and maintain clinical records securely

What is ASRS-V1.1 6QS

The 6-question Adult Self-Report Scale-Version1.1 (ASRS-V1.1 6QS) Screener is a subset of the 18-question Adult ADHD Self-Report Scale-Version1.1 (Adult ASRSV1.1) Symptom Checklist. The Adult ADHD Self-Report Scale-V1.1 6-Question Screener is an instrument consisting of the eighteen DSM-IV-TR criteria. Six of the eighteen questions were found to be the most predictive of symptoms consistent with ADHD. These six questions are the basis for the ASRS-V1.1 6QS.

ASRS-V1.1 6QS Printable PDF

You can create a free account on PsyPack to access fillable PDFs, manuals and educational resources for the ASRS-V1.1 6QS

ASRS-V1.1 6QS Scoring and Interpretation

The original ASRS-V1.1 Screener dichotomous scoring rule, assigned 1 point for items scored above a certain threshold to create a 0-6 scale with a cutpoint of 4 or more to screen positive for ADHD. However, the prevalence estimates for ADHD were high/inconsistent. The 0-6 scoring rules were originally created to make it easier for primary care/clinical use. But, as described in the paper “Kessler, R.C., Adler, L.A., Gruber, M.J., Sarawate, C.A., Spencer, T., Van Brunt, D.L. (2007). Validity of the World Health Organization Adult ADHD Self-Report Scale (ASRS) Screener in a representative sample of health plan members. International Journal of Methods in Psychiatric Research 16(2), 52-65” an alternative 0-24 scale scoring method was found to be more robust and better for research purposes/when studying prevalence and correlates of ADHD compared to the 0-6 scoring system. This alternative system assigns 0 points for a response of “never,” 1 point for “rarely,” 2 points for “sometimes,” 3 points of “often,” and 4 points for a response of “very often” to each question. The points are summed for a range of 0-24, with a cutpoint of 14 or more to screen positive for ADHD. The total score can be classified in four stratum: 0-9=low negative, 10-13=high negative, 14-17=low positive range, and 18-24=high positive range.

The 0-24 scale scoring method provides a cutpoint of 14 or more to screen positive for ADHD.

ASRS-V1.1 6QS Scores and Stratum

Table 4
Score	Stratum
0-9	low negative
10-13	high negative
14-17	low positive range
18-24	high positive range

PsyPack can automatically score the ASRS-V1.1 6QS assessment and prepare corresponding tables and graphs.

Further, PsyPack automatically plots a graph to help you easily track progress over time.

Sample Report of ASRS-V1.1 6QS

Domain

Attention-Deficit/Hyperactivity Disorder (ADHD)

What does ASRS-V1.1 6QS measure

The purpose of the evaluation is to:

help screen for ADHD in adult patients,
provide information that is critical to supplement the diagnostic process.

Administration

Self-administered

Type of outcome tool

Clinical

Assessment modes

Questionnaire

Age and eligibility

18 years and above

Estimated time

Less than 5 minutes

Notes

Since the questionnaire relies on client self-report, all responses should be verified by the clinician, and a definitive diagnosis is made on clinical grounds taking into account how well the client understood the questionnaire, as well as other relevant information from the client.

The questions are designed to stimulate dialogue between you and your patients and to help confirm if they may be suffering from the symptoms of attention-deficit/hyperactivity disorder (ADHD).

Impairments:

Review the entire Symptom Checklist with your patients and evaluate the level of impairment associated with the symptom.
Consider work/school, social and family settings.
Symptom frequency is often associated with symptom severity, therefore the Symptom Checklist may also aid in the assessment of impairments. If your patients have frequent symptoms, you may want to ask them to describe how these problems have affected the ability to work, take care of things at home, or get along with other people such as their spouse/significant other.

History:

Assess the presence of these symptoms or similar symptoms in childhood. Adults who have ADHD need not have been formally diagnosed in childhood. In evaluating a patient’s history, look for evidence of early-appearing and long-standing problems with attention or self-control. Some significant symptoms should have been present in childhood, but full symptomology is not necessary.

Research suggests that the symptoms of ADHD can persist into adulthood, having a significant impact on the relationships, careers, and even the personal safety of your patients who may suffer from it. Because this disorder is often misunderstood, many people who have it do not receive appropriate treatment and, as a result, may never reach their full potential. Part of the problem is that it can be difficult to diagnose, particularly in adults.

As a healthcare professional, you can use the ASRS v1.1 as a tool to help screen for ADHD in adult patients. Insights gained through this screening may suggest the need for a more in-depth clinician interview. The questions in the ASRS v1.1 are consistent with DSM-IV criteria and address the manifestations of ADHD symptoms in adults. Content of the questionnaire also reflects the importance that DSM-IV places on symptoms, impairments, and history for a correct diagnosis.

The checklist takes about 5 minutes to complete and can provide information that is critical to supplement the diagnostic process.

Attribution and References

Kessler, R.C., Adler, L., Ames, M., Demler, O., Faraone, S., Hiripi, E., Howes, M.J., Jin, R., Secnik, K., Spencer, T., Ustun, T.B., Walters, E.E. (2005). The World Health Organization Adult ADHD Self-Report Scale (ASRS). Psychological Medicine, 35(2), 245-256

Official website

Archived link

Kessler RC, Adler LA, Gruber MJ, Sarawate CA, Spencer T, Van Brunt DL. Validity of the World Health Organization Adult ADHD Self-Report Scale (ASRS) Screener in a representative sample of health plan members. Int J Methods Psychiatr Res. 2007;16(2):52-65. doi: 10.1002/mpr.208. PMID: 17623385; PMCID: PMC2044504.

Archived link